News | June 17, 2007

Kensey Nash Announces Results of Study Using the Thromcat Thrombectomy Catheter System

June 18, 2007 — Kensey Nash Corporation today announced that it has completed a European Union (EU) study to assess the device success, safety and performance of the ThromCat Thrombectomy Catheter System during percutaneous coronary intervention (PCI).

The trial enrolled over 60 patients at seven sites, and was designed to study outcomes of patients in both acute and elective PCI settings, who had thrombus present in their native coronary arteries.

The ThromCat System is a mechanical thrombectomy catheter designed to remove thrombus in patients, and is indicated in Europe for use in both coronary and certain peripheral arteries.

Hospital discharge results, presented by the company at the EuroPCR meeting in Barcelona last month, demonstrated over 90% device success, patient safety and desired device performance with 70% thrombus removal by volume. The results of the study also showed strong improvements to TIMI flow measurements, and myocardial blush scores, based on the use of the ThromCat System, with only 1.6% of the patients needing temporary pacing.

The ThromCat mechanical thrombectomy system is a fully disposable catheter system that incorporates HeliFlex technology to flush, macerate, and extract thrombus. An internal rotating helix creates a powerful vacuum to draw thrombus into the catheter and then macerate it, while simultaneously flushing the vessel to aid in the thrombus removal.

For more information:

Related Content

Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome
News | Deep Vein Thrombosis| July 07, 2017
BTG plc recently highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th...
Philips Announces Relaunch of Pioneer Plus IVUS-Guided Catheter
News | Chronic Total Occlusion (CTO)| June 28, 2017
June 28, 2017 — Royal Philips recently announced the relaunch of its Pioneer Plus...
Sponsored Content | Videos | Venous Therapies| June 27, 2017
This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat deep vein th
Teleflex, FDA 510k clearance, TrapLiner Catheter, U.S. launch
Technology | Catheters| March 02, 2017
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
Technology | Pulmonary Embolism| March 01, 2017
March 1, 2017 — BTG plc announced U.S.
Technology | Radial Access| February 17, 2017
Medtronic plc announced that its coronary portfolio will now include the DxTerity Diagnostic Angiography Catheter line...
Mercator MedSystems, DANCE trial data, ISET, LINC, Bullfrog Micro-Infusion Device
News | Peripheral Artery Disease (PAD)| February 15, 2017
Mercator MedSystems announced that the national co-principal investigators of the company’s DANCE trial each presented...
global thrombectomy devices market, Allied Market Research report, 2022
News | Thrombectomy Devices| January 05, 2017
January 5, 2017 — A new report published by Allied Market Research forecasts that the global...
Overlay Init